Alp N J, Allport T D, Van Zanten J, Rodgers B, Sissons J G, Borysiewicz L K
Department of Medicine, Addenbrooke's Hospital, Cambridge, United Kingdom.
J Virol. 1991 Sep;65(9):4812-20. doi: 10.1128/JVI.65.9.4812-4820.1991.
Cell-mediated immunity is important in maintaining the virus-host equilibrium in persistent human cytomegalovirus (HCMV) infection. The HCMV 72-kDa major immediate early 1 protein (IE1) is a target for CD8+ cytotoxic T cells in humans, as is the equivalent 89-kDa protein in mouse. Less is known about responses against this protein by CD4+ T cells, which may be important as direct effector cells or helper cells for antibody and CD8+ responses. Proliferative-T-cell responses to HCMV IE1 were studied in normal seropositive subjects. Peripheral blood mononuclear cells from 85% of seropositive subjects proliferated in response to HCMV from infected fibroblasts, and of these, 73% responded to recombinant baculovirus IE1. Responding cells were predominantly CD3+ CD4+. IE1 antigen preparations, including baculovirus recombinant protein, transfected rat cell nuclei, and synthetic peptides, induced IE1-specific T-cell lines which cross-reacted between the preparations. The fine specificity of these IE1-specific T-cell lines was studied by using overlapping synthetic peptides encompassing the entire sequence of the IE1 protein. The regions of the IE1 molecule recognized were identified and these varied between individuals, possibly reflecting differences in major histocompatibility complex (MHC) class II haplotype. In one subject, the peptide specificities of proliferative and MHC class I-restricted cytotoxic determinants on IE1 were spatially distinct. Thus, no single immunodominant T-cell determinant within HCMV IE1 was identified, suggesting that multiple peptides or a region of the 72-kDa IE1 protein would be required to induce specific T-cell responses in humans.
细胞介导的免疫在维持人类巨细胞病毒(HCMV)持续性感染中的病毒-宿主平衡方面具有重要作用。HCMV 72 kDa主要立即早期1蛋白(IE1)是人类CD8 +细胞毒性T细胞的靶标,在小鼠中与之等效的是89 kDa蛋白。关于CD4 + T细胞针对该蛋白的反应了解较少,而CD4 + T细胞作为直接效应细胞或抗体及CD8 +反应的辅助细胞可能很重要。在正常血清反应阳性的受试者中研究了对HCMV IE1的增殖性T细胞反应。85%血清反应阳性受试者的外周血单核细胞对来自感染成纤维细胞的HCMV产生增殖反应,其中73%对重组杆状病毒IE1有反应。反应细胞主要是CD3 + CD4 +。包括杆状病毒重组蛋白、转染大鼠细胞核和合成肽在内的IE1抗原制剂诱导了在这些制剂之间发生交叉反应的IE1特异性T细胞系。通过使用涵盖IE1蛋白整个序列的重叠合成肽研究了这些IE1特异性T细胞系的精细特异性。确定了IE1分子被识别的区域,这些区域在个体之间有所不同,可能反映了主要组织相容性复合体(MHC)II类单倍型的差异。在一名受试者中,IE1上增殖性和MHC I类限制性细胞毒性决定簇的肽特异性在空间上是不同的。因此,未在HCMV IE1内鉴定出单一的免疫显性T细胞决定簇,这表明在人类中诱导特异性T细胞反应可能需要多种肽或72 kDa IE1蛋白的一个区域。